SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?


To: Silver Knife who wrote (887)5/28/1999 8:51:00 AM
From: Claude Robitaille  Respond to of 2344
 
Globe says Biomira on target ramping up cancer study

Biomira Inc BRA
Shares issued 44,000,000 May 27 close $5.70
Fri 28 May 99 In the News
The Globe and Mail reports in its Friday, May 28, edition that Biomira has
enrolled more than 10 per cent of the patients it requires for an
international phase III clinical study of its cancer vaccine Theratope. The
Globe's Leonard Zehr writes that Biomira says 101 women with advanced
breast cancer have joined the study, which began in December and is
scheduled to take four years. Biomira says it's on target ramping up the
study. The clinical trial will study 900 women at 75 sites worldwide,
making it the largest ever for advanced breast cancer. Biomira plans to
analyze interim data from the phase III study at the end of 2000. Biomira
and Chiron Corp. of Emeryville, Calif., are sharing costs of the
$30-million phase III trial, which precedes an application for market
approval. Theratope already has been tested in more 350 patients in phase I
and II trials in Canada, the United States and Britain. In one study,
patients treated with Theratope had a median survival rate of 26.5 months,
compared with 9.2 months for patients in a control group.
(c) Copyright 1999 Canjex Publishing Ltd. canada-stockwatch.com



To: Silver Knife who wrote (887)5/28/1999 8:54:00 AM
From: Claude Robitaille  Respond to of 2344
 
Check this out. Someone who when to the annual meeting.

ANNUAL MEETING NOTE PART 1
post.messages.yahoo.com

ANNUAL MEETING NOTE PART 2
post.messages.yahoo.com



To: Silver Knife who wrote (887)6/2/1999 2:52:00 PM
From: Jibacoa  Read Replies (2) | Respond to of 2344
 
Silver:

Biomira seems to be finding support at these levels in spite of the general market.

Right now with 93,500 shares traded it shows no change for the day.

The BID/ASK ratio is 40/20 at present.

Will keep watching it and BUYING IT on ANY DIPS,

Regards, and Good luck

J